Tide Pharmaceutical

Company Drug

Sino Biopharmaceutical’s Tulobuterol Patch Gains NMPA Approval

Fineline Cube Feb 7, 2025

China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced that its subsidiary Beijing Tide Pharmaceutical Co., Ltd...

Company Drug

Sino Biopharmaceutical’s TDI01 Receives Clinical Trial Approval for COVID-19

Fineline Cube Sep 27, 2022

China’s Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its subsidiary, Beijing Tide Pharmaceutical Co....

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod